Complement activation by case-control plasmas from RV144.
收藏NIAID Data Ecosystem2026-03-10 收录
数据链接：
官方服务：
资源简介：
(XLSX)
应用场景：
创建时间：
2017-07-05
相关数据集
Data from: Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
Article Authors Metrics Comments Related Content Abstract Introduction Materials and methods Results Discussion Limitations Conclusion Supporting information Acknowledgments References Reader Comments
DataONE2017-09-15 更新80
Vaccine-Induced Sero-Positivity/Sero-Reactivity (VISP/R) through Study Week 42.
Results are counted as positive (or reactive) if these were the results at any time from after first vaccination through study week 42.*Western blot (WB) was done only if the EIA was positive (reactiv
Figshare2015-12-02 更新30
Dataset from Immunogenicity and Safety of a Single Dose or Two Doses Given 28 Days Apart of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Subjects Aged 6 Months or Older in India
The aim of the study was to generate immunogenicity and safety data in the whole population to support registration of the Quadrivalent Influenza Vaccine (QIV) in India: Primary objective: - T
NIAID Data Ecosystem10
Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901
Background Development of a tuberculosis vaccine to boost BCG is a major international health priority. SRL172, an inactivated whole cell booster derived from a non-tuberculous mycobacterium, is the o
NIAID Data Ecosystem40
Dataset from Partially-blind Immunogenicity and Safety Study of GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults.
This study is designed to assess the safety and immunogenicity of a GSK Biologicals' investigational vaccine GSK2321138A in adults 18 years old and older. This study is also designed to assess the lot
NIAID Data Ecosystem20
